Market Cap

Orgenesis Inc. Market Capitalization:

$775,695

USD as of Jan. 1, 2026

business Orgenesis Inc. Company Profile

Orgenesis Inc. Main Stock Listing

NASDAQ: ORGS

Market Capitalization History of Orgenesis Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Orgenesis Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $775,695 -89.79%
Jan. 1, 2025 $7.6 M -45.33%
Jan. 1, 2024 $13.9 M -78.66%
Jan. 1, 2023 $65.1 M -22.68%
Jan. 1, 2022 $84.3 M -51.92%
Jan. 1, 2021 $175.2 M 25.68%
Jan. 1, 2020 $139.4 M 19.91%
Jan. 1, 2019 $116.3 M -50.23%
Jan. 1, 2018 $233.6 M 76.42%
Jan. 1, 2017 $132.4 M 24.24%
Jan. 1, 2016 $106.6 M -48.44%
Jan. 1, 2015 $206.7 M 14.29%
Jan. 1, 2014 $180.9 M -13.85%
Jan. 1, 2013 $210.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Sell the task first.
Automate what repeats.
Publish a paid offer in minutes. Learn what buyers actually pay for before building agents, workflows, or services nobody buys.
Get Started Free
For AI operators, consultants, & service builders

Orgenesis Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Orgenesis Inc. has the following listings and related stock indices.


Stock: NASDAQ: ORGS

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.